Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study compares the success rate of letrozole and misoprostol versus misoprostol alone for medical termination of first-trimester pregnancy.
According to the American college of obstetricians and gynecologists (2005), medical abortion is an acceptable alternative for surgical procedures in pregnant women with gestational age of less than 49 days based on the last menstrual period
Oral or vaginal misoprostol causes complete abortion in almost 85% of cases within seven days before the 12th week
letrozole administration with misoprostol raises the rate of complete abortion
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| study group | Experimental | 2 tablets of Letrozole 2.5 mg will be given as single daily doses, 5 mg per day for two days at home and the third dose will be given on admission to hospital on day 3 and will be followed by vaginal misoprostol 800 mcg every three hours up to maximum three doses. |
|
| control group | Placebo Comparator | 2 tablets of placebo will be given as a single daily dose, for two days at home and will be admitted on day 3 and continue treatment with misoprostol 800 mcg every three hours up to maximum three doses |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Letrozole then misoprostol | Drug | total dose 5 mg per day for 3 days then Misoprosrol 800mcg will be given to all patients for induction of abortion |
|
| Measure | Description | Time Frame |
|---|---|---|
| complete abortion rate | Incidence of complete miscarriage | 9 hours |
| time from induction to abortion | induction to abortion time interval | 9 hours |
| Measure | Description | Time Frame |
|---|---|---|
| Need for surgical evacuation of the products of conception | how many women will undergo dilatation and curettage after failed medical induction of abortion | 9 hours |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| AHMED SAMY | Contact | +201100681167 | ahmedsamy8233@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| AHMED SAMY | Cairo University | Principal Investigator |
Not provided
Not provided
| ID | Term |
|---|---|
| D000030 | Abortion, Missed |
| ID | Term |
|---|---|
| D000022 | Abortion, Spontaneous |
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| placebo then misoprostol | Drug | placebo tablets for 3 days then Misoprosrol 800mcg will be given to all patients for induction of abortion |
|